Relationship Between Bone Mineral Density and Ovarian Function and Thyroid Function in Perimenopausal Women with Endometriosis: a Prospective Study

Overview

Journal BMC Womens Health

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2022 Apr 28

PMID 35477494

Authors

Mari Uehara

Osamu Wada-Hiraike

Mana Hirano

Kaori Koga

Noriko Yoshimura

Sakae Tanaka

Yutaka Osuga

Affiliations

Soon will be listed here.

Abstract

Background: In women with endometriosis, the association between ovarian function, hormones, and bone mineral density (BMD) is unclear. Therefore, this study aimed to elucidate the association between changes in bone mineral density (BMD) and clinical data, such as ovarian reserves, in perimenopausal women with endometriosis.

Methods: In this prospective study, we evaluated 207 female patients who visited the Department of Obstetrics and Gynecology at the University of Tokyo Hospital between December 2015 and December 2020. We included patients aged ≥ 40 years with a history of endometriosis or who presented with endometriosis lesions. Patients with a history of smoking, steroid administration, autoimmune diseases, dyslipidaemia, and heart disease were excluded. During the study period, patients who underwent two tests, an initial and a follow-up test (n = 142, average age: 45.02 years, average BMD: 1.16 g/cm), were evaluated at regular intervals based on the annual rate of change in BMD.

Results: There was a weak negative correlation between the follicle-stimulating hormone (FSH) and BMD and a weak positive correlation between the anti-Müllerian hormone (AMH) and BMD. The annual rate of change in BMD showed a very weak correlation with thyroid-stimulating hormone (TSH) levels. A large decline in BMD was associated with high TSH levels and higher average age at menopause. Patients with higher TSH exhibited a higher rate of decrease in BMD than those without.

Conclusions: High FSH or low AMH levels are associated with decreased BMD. Decreased ovarian reserve is associated with decreased BMD in perimenopausal women with endometriosis. High TSH levels increase the risk of BMD loss. This finding may suggest that women with endometriosis should undergo bone scanning to rule out the possibility of reduced bone mass and subsequent increased risk of fracture.

Citing Articles

Study on gut microbiota and metabolomics in postmenopausal women.

Xie X, Song J, Wu Y, Li M, Guo W, Li S BMC Womens Health. 2024; 24(1):608.

PMID: 39548431 PMC: 11566192. DOI: 10.1186/s12905-024-03448-7.

Genetic Prediction of Osteoporosis by Anti-Müllerian Hormone Levels and Reproductive Factors in Women: A Mendelian Randomization Study.

Li Y, Lai J, Wu W, Ling S, Dai Y, Zhong Z Calcif Tissue Int. 2024; 115(1):41-52.

PMID: 38743269 PMC: 11153262. DOI: 10.1007/s00223-024-01220-5.

Histone lactylation promotes cell proliferation, migration and invasion through targeting HMGB1 in endometriosis.

Chen J, Qin P, Sun Y, Han S J Biomed Res. 2023; 37(6):470-478.

PMID: 37945340 PMC: 10687535. DOI: 10.7555/JBR.37.20230095.

References

Poppe K, Velkeniers B, Glinoer D . The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab. 2008; 4(7):394-405. DOI: 10.1038/ncpendmet0846. View

Burger H, Hale G, Robertson D, Dennerstein L . A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update. 2007; 13(6):559-65. DOI: 10.1093/humupd/dmm020. View

Fistarol M, Rezende C, Figueiredo Campos A, Kakehasi A, Geber S . Time since menopause, but not age, is associated with increased risk of osteoporosis. Climacteric. 2019; 22(5):523-526. DOI: 10.1080/13697137.2019.1634046. View

Gosset A, Escanes C, Pouilles J, Vidal F, Tanguy Le Gac Y, Plu-Bureau G . Bone mineral density in women with deep infiltrating endometriosis who have undergone early bilateral oophorectomy. Menopause. 2020; 28(3):300-306. DOI: 10.1097/GME.0000000000001696. View

Riggs B, Khosla S, Melton 3rd L . A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998; 13(5):763-73. DOI: 10.1359/jbmr.1998.13.5.763. View

Sinaii N, Cleary S, Ballweg M, Nieman L, Stratton P . High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod. 2002; 17(10):2715-24. DOI: 10.1093/humrep/17.10.2715. View

Chapron C, Marcellin L, Borghese B, Santulli P . Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019; 15(11):666-682. DOI: 10.1038/s41574-019-0245-z. View

Kim Y, Cha S, Kim H . Serum anti-Müllerian hormone levels decrease after endometriosis surgery. J Obstet Gynaecol. 2017; 37(3):342-346. DOI: 10.1080/01443615.2016.1239071. View

. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001; 285(6):785-95. DOI: 10.1001/jama.285.6.785. View

10.

Bulun S, Yilmaz B, Sison C, Miyazaki K, Bernardi L, Liu S . Endometriosis. Endocr Rev. 2019; 40(4):1048-1079. PMC: 6693056. DOI: 10.1210/er.2018-00242. View

11.

Yoshimura N, Kasamatsu T, Sakata K, Hashimoto T, Cooper C . The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study. J Bone Miner Metab. 2002; 20(5):303-10. DOI: 10.1007/s007740200044. View

12.

Aghajanova L, Lindeberg M, Carlsson I, Stavreus-Evers A, Zhang P, Scott J . Receptors for thyroid-stimulating hormone and thyroid hormones in human ovarian tissue. Reprod Biomed Online. 2009; 18(3):337-47. DOI: 10.1016/s1472-6483(10)60091-0. View

13.

Melton 3rd L, Leibson C, Good A, Achenbach S, Oberg A, Khosla S . Long-term fracture risk among women with proven endometriosis. Fertil Steril. 2006; 86(6):1576-83. DOI: 10.1016/j.fertnstert.2006.05.036. View

14.

Finkelstein J, Brockwell S, Mehta V, Greendale G, Sowers M, Ettinger B . Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab. 2007; 93(3):861-8. PMC: 2266953. DOI: 10.1210/jc.2007-1876. View

15.

Randolph Jr J, Zheng H, Sowers M, Crandall C, Crawford S, Gold E . Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab. 2010; 96(3):746-54. PMC: 3047231. DOI: 10.1210/jc.2010-1746. View

16.

Jamil Z, Fatima S, Ahmed K, Malik R . Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers. Dis Markers. 2016; 2016:5246217. PMC: 4764725. DOI: 10.1155/2016/5246217. View

17.

Zebaze R, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price R . Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010; 375(9727):1729-36. DOI: 10.1016/S0140-6736(10)60320-0. View

18.

Zaidi M, Turner C, Canalis E, Pacifici R, Sun L, Iqbal J . Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss. Curr Osteoporos Rep. 2009; 7(4):118-26. DOI: 10.1007/s11914-009-0021-4. View

19.

Gambacciani M, Levancini M . Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Prz Menopauzalny. 2015; 13(4):213-20. PMC: 4520366. DOI: 10.5114/pm.2014.44996. View

20.

Romanski P, Brady P, Farland L, Thomas A, D Hornstein M . The effect of endometriosis on the antimüllerian hormone level in the infertile population. J Assist Reprod Genet. 2019; 36(6):1179-1184. PMC: 6603105. DOI: 10.1007/s10815-019-01450-9. View